Anteris adds two directors to Board, including former Surmodics chair Susan Knight

Filed May 13, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• medium

  Susan Knight appointed as Class I Director through 2028, will serve on Audit and Risk Committee. Knight previously chaired Surmodics board and brings CFO and audit committee experience from MTS Systems.

  Item 5.02 verify on EDGAR →
• medium

  Stephen Denaro rejoins Board as Class II Director with term expiring at 2026 annual meeting. Filing notes he has deep knowledge of Company's strategic priorities from prior service.

  Item 5.02 verify on EDGAR →
• low

  Knight to receive $250,000 initial RSU grant vesting over three years, subject to stockholder approval per ASX listing rules. Both directors eligible for $125,000 annual RSU grants plus standard cash retainers.

  Item 5.02 verify on EDGAR →